Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Bristol-Myers Squibb (NY:BMY)

43.61 -0.02 (-0.05%)
Streaming Delayed Price Updated: 11:09 AM EDT, Oct 20, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 3,195,409
Open 43.66
Bid (Size) 43.61 (3)
Ask (Size) 43.62 (11)
Prev. Close 43.63
Today's Range 43.51 - 43.95
52wk Range 42.96 - 63.30
Shares Outstanding 2,222,113,553
Dividend Yield 5.69%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
2 High-Yield Dividend Stocks Too Cheap to Ignore
They are both yielding above 5%. 
Via The Motley Fool
Topics Intellectual Property World Trade
3 S&P 500 Stocks We Find Risky
The S&P 500 (^GSPC) is home to the biggest and most well-known companies in the market, making it a go-to index for investors seeking stability. But not all large-cap stocks are created equal - some... 
Via StockStory
Topics Stocks

Performance

YTD
-23.2%
-23.2%
1 Month
-3.1%
-3.1%
3 Month
-6.6%
-6.6%
6 Month
-10.9%
-10.9%
1 Year
-16.3%
-16.3%

More News

Read More
This Drug Discovery Stock Is Leading the Charge In Bringing AI to Healthcare. But Is It a Buy?
Via The Motley Fool
Topics Artificial Intelligence
Wall Street's Most Accurate Analysts Spotlight On 3 Health Care Stocks With Over 3% Dividend Yields
Via Benzinga
Bristol Myers Squibb To Acquire Orbital Therapeutics In $1.5B Deal
Via Stocktwits
Price Over Earnings Overview: Bristol-Myers Squibb
Via Benzinga
Bristol Myers Squibb to Present Data at ESMO® 2025 Showcasing Progress of Oncology Portfolio Across Diverse Tumor Types
From Bristol Myers Squibb
Via Business Wire
Branded Pharmaceuticals Stocks Q2 Earnings Review: Supernus Pharmaceuticals (NASDAQ:SUPN) Shines
Via StockStory
Topics Artificial Intelligence Intellectual Property
Bristol Myers Expands Cell Therapy Portfolio With Orbital Therapeutics Acquisition
Via Benzinga
Bristol Myers Squibb Strengthens and Diversifies Cell Therapy Portfolio with Acquisition of Orbital Therapeutics
From Bristol Myers Squibb
Via Business Wire
Bristol Myers Squibb and TV Host Gail Simmons Tackle Stigma in Schizophrenia with New Initiative Spotlighting the Power of Support and Connection
From Bristol Myers Squibb
Via Business Wire
3 Value Stocks with Warning Signs
Via StockStory
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Offers a High Dividend Yield and Strong Profitability
Via Chartmill
BRISTOL-MYERS SQUIBB CO (NYSE:BMY) Presents a Strong Value Investment Case
Via Chartmill
These 3 Pharma Stocks Are Rallying – And Still Trade Absurdly Cheap
Via Benzinga
What's going on in today's session: S&P500 movers
Via Chartmill
Nanobiotix Stock Soars on Breakthrough Esophageal Cancer Data, Igniting Biotech Hopes
Via MarketMinute
Healthcare Sector Defies Headwinds, Rallies on Wall Street Amidst Shutdown and Jobs Data
Via MarketMinute
Topics Artificial Intelligence Economy Intellectual Property
In today's session, there are S&P500 stocks with remarkable trading volume.
Via Chartmill
Health Care Stocks Rally, Nike Beats The Street: What's Moving Markets Wednesday?
Via Benzinga
Why Is Bristol-Myers Squibb (BMY) Stock Rocketing Higher Today
Via StockStory
Topics Artificial Intelligence
Wall Street's Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 4% Dividend Yields
Via Benzinga
Bristol Myers Squibb’s Anti-MTBR-Tau-Targeting Antibody, BMS-986446, Granted Fast Track Designation by U.S. FDA for the Treatment of Alzheimer’s Disease
From Bristol Myers Squibb
Via Business Wire
Pharmaceutical Stocks Soar as White House Unveils Drug-Pricing Agreement, AbbVie Leads the Charge
Via MarketMinute
Topics Economy Government World Trade
Trump's Plan To Lower U.S. Drug Prices Faces Big Test
Via Investor's Business Daily
Topics Government

Frequently Asked Questions

Is Bristol-Myers Squibb publicly traded?
Yes, Bristol-Myers Squibb is publicly traded.
What exchange does Bristol-Myers Squibb trade on?
Bristol-Myers Squibb trades on the New York Stock Exchange
What is the ticker symbol for Bristol-Myers Squibb?
The ticker symbol for Bristol-Myers Squibb is BMY on the New York Stock Exchange
What is the current price of Bristol-Myers Squibb?
The current price of Bristol-Myers Squibb is 43.61
When was Bristol-Myers Squibb last traded?
The last trade of Bristol-Myers Squibb was at 10/20/25 11:09 AM ET
What is the market capitalization of Bristol-Myers Squibb?
The market capitalization of Bristol-Myers Squibb is 96.91B
How many shares of Bristol-Myers Squibb are outstanding?
Bristol-Myers Squibb has 97B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.